Literature DB >> 33539963

Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway.

Yonghe Ma1, Jamie Harris1, Ping Li1, Haiming Cao2.   

Abstract

Bile acids, regarded as the body's detergent for digesting lipids, also function as critical signaling molecules that regulate cholesterol and triglyceride levels in the body. Bile acids are the natural ligands of the nuclear receptor, FXR, which controls an intricate network of cellular pathways to maintain metabolic homeostasis. In recent years, growing evidence supports that many cellular actions of the bile acid/FXR pathway are mediated by long non-coding RNAs (lncRNAs), and lncRNAs are in turn powerful regulators of bile acid levels and FXR activities. In this review, we highlight the substantial progress made in the understanding of the functional and mechanistic role of lncRNAs in bile acid metabolism and how lncRNAs connect bile acid activity to additional metabolic processes. We also discuss the potential of lncRNA studies in elucidating novel molecular mechanisms of the bile acid/FXR pathway and the promise of lncRNAs as potential diagnostic markers and therapeutic targets for diseases associated with altered bile acid metabolism. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33539963      PMCID: PMC8437140          DOI: 10.1016/j.mce.2021.111191

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  122 in total

Review 1.  Exosomal non-coding RNAs: a promising cancer biomarker.

Authors:  Huan Yang; Hailong Fu; Wenrong Xu; Xu Zhang
Journal:  Clin Chem Lab Med       Date:  2016-12-01       Impact factor: 3.694

Review 2.  Role of long non-coding RNAs in metabolic control.

Authors:  Eunbyul Ji; Chongtae Kim; Wook Kim; Eun Kyung Lee
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-12-27       Impact factor: 4.490

3.  Individual bile acids have differential effects on bile acid signaling in mice.

Authors:  Peizhen Song; Cheryl E Rockwell; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-09       Impact factor: 4.219

4.  Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.

Authors:  Sungsoon Fang; Ji Miao; Lingjin Xiang; Bhaskar Ponugoti; Eckardt Treuter; Jongsook Kim Kemper
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

5.  Bile acids: natural ligands for an orphan nuclear receptor.

Authors:  D J Parks; S G Blanchard; R K Bledsoe; G Chandra; T G Consler; S A Kliewer; J B Stimmel; T M Willson; A M Zavacki; D D Moore; J M Lehmann
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

6.  Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.

Authors:  Li Zhang; Zhihong Yang; Jocelyn Trottier; Olivier Barbier; Li Wang
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

Review 7.  Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.

Authors:  Geoffrey Porez; Janne Prawitt; Barbara Gross; Bart Staels
Journal:  J Lipid Res       Date:  2012-05-01       Impact factor: 5.922

8.  Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP.

Authors:  Jongsook Kim Kemper; Hwajin Kim; Ji Miao; Sonali Bhalla; Yangjin Bae
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Farnesoid X receptor regulates bile acid-amino acid conjugation.

Authors:  Parinaz C Pircher; Jennifer L Kitto; Mary L Petrowski; Rajendra K Tangirala; Eric D Bischoff; Ira G Schulman; Stefan K Westin
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

10.  Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.

Authors:  Hui Zhou; Weifeng Shen; Hongxing Zou; Qingshan Lv; Pingyang Shao
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.